Newronika

Newronika is a biotech company in Milan, Italy, founded in 2016. It has raised $25.7M across 2 rounds, most recently a $15.9M Series B in February 2025.

The brain leads. Therapy adapts.

Headquarters
Milan
Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$25.7M
Last Round
$15.9M Series BFeb 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Newronika develops αDBS, an adaptive deep brain stimulation platform for Parkinson's disease that senses full-spectrum brain signals every ten minutes and automatically adjusts stimulation to keep patients in their therapeutic window. The CE-marked, clinically validated system is built on a patented proportional control algorithm and a cloud-based platform called WebBioBank that stores longitudinal neural data to continuously refine therapy. In a first-of-its-kind double-blind randomized crossover clinical trial, 86% of patients preferred αDBS over conventional DBS.

Summary

It lists 11–50 employees. It has raised $25.7M in total across 2 rounds, most recently a $15.9M Series B round in Feb 2025. Investors include Omnes Capital, Indaco Venture Partners and Innogest Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BFeb 2025
$15.9M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Newronika on Indexed.vc
<a href="https://indexed.vc/companies/newronika"><img src="https://indexed.vc/api/badge/company/newronika" alt="Newronika on Indexed.vc" width="260" height="76" /></a>